The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status

A Systematic Review

Hollie Speer, Nathan M D'Cunha, Michal Botek, Andrew J McKune, Domenico Sergi, Ekavi Georgousopoulou, Duane D Mellor, Nenad Naumovski

Research output: Contribution to journalArticle

1 Downloads (Pure)

Abstract

The prevalence of cardiovascular disease (CVD) is rising worldwide, remaining the major cause of death in developed countries. Polyphenols have been shown to have cardioprotective properties; however, their impact on iron bioavailability and potential impact on other aspects of health is unclear. A systematic review was undertaken to evaluate the current status of the relationship between habitual polyphenol consumption, iron status, and circulating biomarkers of CVD. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines, searches were performed across 5 electronic databases (PubMed, Cochrane Library, Scopus, Web of Science, and CINAHL) to identify randomized controlled trials which investigated the effects of polyphenol consumption on inflammatory markers, serum lipid profile, and iron absorption and bioavailability. In total, 1174 records were identified, with only 7 studies meeting the inclusion criteria. The selected studies involved 133 participants and used a variety of foods and supplements, including olive oil and cherries, rich in polyphenols including hydroxytyrosol, quercetin, and resveratrol, as well as catechin enriched drinks. The duration of the studies ranged from between 56 and 145 days, with total polyphenolic content of the food items and supplements ranging from 45 to 1015 mg (per 100 g). Polyphenols did not appear to interfere with iron status, and most studies reported improvements in inflammatory markers and lipid profile. While these results are promising, the limited number of studies and considerable heterogeneity across the interventions support the need for more extensive trials assessing the relationship between polyphenol intake, iron bioavailability, and CVD risk.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalNutrition and metabolic insights
Volume12
DOIs
Publication statusPublished - 21 Oct 2019

Fingerprint

Polyphenols
Cardiovascular Diseases
Iron
Biomarkers
Biological Availability
Dietary Supplements
Lipids
Catechin
Quercetin
Developed Countries
PubMed
Libraries
Meta-Analysis
Cause of Death
Randomized Controlled Trials
Databases
Guidelines
Health

Cite this

Speer, Hollie ; D'Cunha, Nathan M ; Botek, Michal ; McKune, Andrew J ; Sergi, Domenico ; Georgousopoulou, Ekavi ; Mellor, Duane D ; Naumovski, Nenad. / The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status : A Systematic Review. In: Nutrition and metabolic insights. 2019 ; Vol. 12. pp. 1-12.
@article{c4bcae434c9b4fd88e044e854ef2595f,
title = "The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review",
abstract = "The prevalence of cardiovascular disease (CVD) is rising worldwide, remaining the major cause of death in developed countries. Polyphenols have been shown to have cardioprotective properties; however, their impact on iron bioavailability and potential impact on other aspects of health is unclear. A systematic review was undertaken to evaluate the current status of the relationship between habitual polyphenol consumption, iron status, and circulating biomarkers of CVD. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines, searches were performed across 5 electronic databases (PubMed, Cochrane Library, Scopus, Web of Science, and CINAHL) to identify randomized controlled trials which investigated the effects of polyphenol consumption on inflammatory markers, serum lipid profile, and iron absorption and bioavailability. In total, 1174 records were identified, with only 7 studies meeting the inclusion criteria. The selected studies involved 133 participants and used a variety of foods and supplements, including olive oil and cherries, rich in polyphenols including hydroxytyrosol, quercetin, and resveratrol, as well as catechin enriched drinks. The duration of the studies ranged from between 56 and 145 days, with total polyphenolic content of the food items and supplements ranging from 45 to 1015 mg (per 100 g). Polyphenols did not appear to interfere with iron status, and most studies reported improvements in inflammatory markers and lipid profile. While these results are promising, the limited number of studies and considerable heterogeneity across the interventions support the need for more extensive trials assessing the relationship between polyphenol intake, iron bioavailability, and CVD risk.",
keywords = "Polyphenol, CVD, atherosclerosis, iron status",
author = "Hollie Speer and D'Cunha, {Nathan M} and Michal Botek and McKune, {Andrew J} and Domenico Sergi and Ekavi Georgousopoulou and Mellor, {Duane D} and Nenad Naumovski",
note = "{\circledC} The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",
year = "2019",
month = "10",
day = "21",
doi = "10.1177/1178638819882739",
language = "English",
volume = "12",
pages = "1--12",
journal = "Nutrition and metabolic insights",
issn = "1178-6388",

}

The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status : A Systematic Review. / Speer, Hollie; D'Cunha, Nathan M; Botek, Michal; McKune, Andrew J; Sergi, Domenico; Georgousopoulou, Ekavi; Mellor, Duane D; Naumovski, Nenad.

In: Nutrition and metabolic insights, Vol. 12, 21.10.2019, p. 1-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status

T2 - A Systematic Review

AU - Speer, Hollie

AU - D'Cunha, Nathan M

AU - Botek, Michal

AU - McKune, Andrew J

AU - Sergi, Domenico

AU - Georgousopoulou, Ekavi

AU - Mellor, Duane D

AU - Naumovski, Nenad

N1 - © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PY - 2019/10/21

Y1 - 2019/10/21

N2 - The prevalence of cardiovascular disease (CVD) is rising worldwide, remaining the major cause of death in developed countries. Polyphenols have been shown to have cardioprotective properties; however, their impact on iron bioavailability and potential impact on other aspects of health is unclear. A systematic review was undertaken to evaluate the current status of the relationship between habitual polyphenol consumption, iron status, and circulating biomarkers of CVD. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines, searches were performed across 5 electronic databases (PubMed, Cochrane Library, Scopus, Web of Science, and CINAHL) to identify randomized controlled trials which investigated the effects of polyphenol consumption on inflammatory markers, serum lipid profile, and iron absorption and bioavailability. In total, 1174 records were identified, with only 7 studies meeting the inclusion criteria. The selected studies involved 133 participants and used a variety of foods and supplements, including olive oil and cherries, rich in polyphenols including hydroxytyrosol, quercetin, and resveratrol, as well as catechin enriched drinks. The duration of the studies ranged from between 56 and 145 days, with total polyphenolic content of the food items and supplements ranging from 45 to 1015 mg (per 100 g). Polyphenols did not appear to interfere with iron status, and most studies reported improvements in inflammatory markers and lipid profile. While these results are promising, the limited number of studies and considerable heterogeneity across the interventions support the need for more extensive trials assessing the relationship between polyphenol intake, iron bioavailability, and CVD risk.

AB - The prevalence of cardiovascular disease (CVD) is rising worldwide, remaining the major cause of death in developed countries. Polyphenols have been shown to have cardioprotective properties; however, their impact on iron bioavailability and potential impact on other aspects of health is unclear. A systematic review was undertaken to evaluate the current status of the relationship between habitual polyphenol consumption, iron status, and circulating biomarkers of CVD. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines, searches were performed across 5 electronic databases (PubMed, Cochrane Library, Scopus, Web of Science, and CINAHL) to identify randomized controlled trials which investigated the effects of polyphenol consumption on inflammatory markers, serum lipid profile, and iron absorption and bioavailability. In total, 1174 records were identified, with only 7 studies meeting the inclusion criteria. The selected studies involved 133 participants and used a variety of foods and supplements, including olive oil and cherries, rich in polyphenols including hydroxytyrosol, quercetin, and resveratrol, as well as catechin enriched drinks. The duration of the studies ranged from between 56 and 145 days, with total polyphenolic content of the food items and supplements ranging from 45 to 1015 mg (per 100 g). Polyphenols did not appear to interfere with iron status, and most studies reported improvements in inflammatory markers and lipid profile. While these results are promising, the limited number of studies and considerable heterogeneity across the interventions support the need for more extensive trials assessing the relationship between polyphenol intake, iron bioavailability, and CVD risk.

KW - Polyphenol

KW - CVD

KW - atherosclerosis

KW - iron status

UR - http://www.mendeley.com/research/effects-dietary-polyphenols-circulating-cardiovascular-disease-biomarkers-iron-status-systematic-rev

U2 - 10.1177/1178638819882739

DO - 10.1177/1178638819882739

M3 - Article

VL - 12

SP - 1

EP - 12

JO - Nutrition and metabolic insights

JF - Nutrition and metabolic insights

SN - 1178-6388

ER -